| 1 |
Zhang T, Yu Z, Gao S, Zhang Y, Wang C, Jian S, Wang L, Gou L, Li J, Ma M, Song H. Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis. Pediatr Rheumatol Online J 2023;21:25. [PMID: 36927380 DOI: 10.1186/s12969-023-00807-w] [Reference Citation Analysis]
|
| 2 |
Kalashnikova EM, Raupov RK, Lyubimova NA, Kuchinskaya EM, Masalova VV, Isupova EA, Gaidar EV, Dubko MF, Snegireva LS, Sorokina LS, Kornishina TL, Kaneva MA, Chikova IA, Likhacheva TS, Kolobova OL, Kalashnikova OV, Chasnyk VG, Kostik MM. The experience of rituximab therapy in patients with juvenile systemic lupus erythematosus: the preliminary results of two-center cohort study. Ross vestn perinatol pediatr 2023;68:74-84. [DOI: 10.21508/1027-4065-2023-68-1-74-84] [Reference Citation Analysis]
|
| 3 |
Smith EMD, Lythgoe H, Hedrich CM. Current views on lupus in children. Curr Opin Rheumatol 2023;35:68-81. [PMID: 36286724 DOI: 10.1097/BOR.0000000000000913] [Reference Citation Analysis]
|
| 4 |
Liu X, Peng Y, Cai S. The efficacy and safety of cyclosporine in children with systemic lupus erythematosus: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2023;102:e32314. [PMID: 36827060 DOI: 10.1097/MD.0000000000032314] [Reference Citation Analysis]
|
| 5 |
Miquel CH, Faz-Lopez B, Guéry JC. Influence of X chromosome in sex-biased autoimmune diseases. J Autoimmun 2023;:102992. [PMID: 36641351 DOI: 10.1016/j.jaut.2023.102992] [Reference Citation Analysis]
|
| 6 |
Hall J, Rosado M, Wohrley JD, Bandi S, Kent PM, Jandeska SE, Murphy J, Wilkerson MK. Pericardial Effusion Causing Cardiac Tamponade in a 10-Year-Old Male. Pediatrics 2023;151:e2022057467. [PMID: 36514898 DOI: 10.1542/peds.2022-057467] [Reference Citation Analysis]
|
| 7 |
Ma J, Zhang H, Chu W, Wang P, Chen H, Zhang Y, Wang G. Construction of molecular subgroups in childhood systemic lupus erythematosus using bioinformatics. Medicine (Baltimore) 2022;101:e32274. [PMID: 36595784 DOI: 10.1097/MD.0000000000032274] [Reference Citation Analysis]
|
| 8 |
Wenderfer SE, Orjuela A, Dionne J. How common is chronic kidney disease in children with lupus nephritis? Pediatr Nephrol 2022. [PMID: 36525081 DOI: 10.1007/s00467-022-05848-z] [Reference Citation Analysis]
|
| 9 |
Zhang T, Yu Z, Gao S, Zhang Y, Wang C, Jian S, Wang L, Gou L, Li J, Ma M, Song H. Clinical phenotypes and prognosis of cytomegalovirus infection in the pediatric systemic lupus erythematosus: a longitudinal analysis.. [DOI: 10.21203/rs.3.rs-2354022/v1] [Reference Citation Analysis]
|
| 10 |
de Amorim JC, Sepresse SR, Vivaldo JF, Julio PR, Kishimoto ST, Marini R, Fernandes PT, Costallat LTL, Appenzeller S. Cognitive Performance in Patients with Systemic Lupus Erythematosus Using the Ped-ANAM. Cells 2022;11. [PMID: 36552818 DOI: 10.3390/cells11244054] [Reference Citation Analysis]
|
| 11 |
Sakamoto AP, Silva CA, Islabão AG, Novak GV, Molinari B, Nogueira PK, Pereira RMR, Saad-Magalhães C, Clemente G, Piotto DP, Aikawa NE, Pitta AC, Trindade VC, Appenzeller S, Carvalho LM, Rabelo-Junior CN, Fonseca AR, Sztajnbok FR, Santos MC, Bica BE, Sena EG, Moraes AJ, Fraga MM, Robazzi TC, Spelling PF, Scheibel IM, Cavalcanti AS, Matos EN, Guimarães LJ, Santos FP, Mota LMH, Bonfá E, Terreri MT; Brazilian Childhood-onset Systemic Lupus Erythematosus Registry Group. Chronic kidney disease in patients with childhood-onset systemic lupus erythematosus. Pediatr Nephrol 2022. [PMID: 36409367 DOI: 10.1007/s00467-022-05811-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Felix A, Delion F, Suzon B, Martin E, Ogrizek A, Mohamed Sahnoun M, Hospice C, Armougon A, Cuadro E, Elenga N, Dramé M, Bader-Meunier B, Deligny C, Hatchuel Y. Systemic lupus of pediatric onset in Afro-Caribbean children: a cohort study in the French West Indies and French Guiana. Pediatr Rheumatol Online J 2022;20:95. [PMID: 36371201 DOI: 10.1186/s12969-022-00759-7] [Reference Citation Analysis]
|
| 13 |
Lu Y, Huang XM. Autoimmune hemolytic anemia as an initial presentation in children with systemic lupus erythematosus: two case reports. J Int Med Res 2022;50:3000605221115390. [PMID: 35971316 DOI: 10.1177/03000605221115390] [Reference Citation Analysis]
|
| 14 |
Koker O, Aktay Ayaz N. Autoimmune and autoinflammatory diseases with mucocutaneous manifestations: A pediatric rheumatology perspective. Int J Dermatol 2022. [PMID: 35843911 DOI: 10.1111/ijd.16352] [Reference Citation Analysis]
|
| 15 |
Wen L, Chen Z, Jin Z, Pan W, Liu L, Wu M, Ding F, Hu H, Ding X, Wei H, Zou Y, Qian X, Wang M, Wu J, Tao J, Tan J, Da Z, Zhang M, Li J, Feng X, Liang J, Zhang H, Sun L. Clinical and laboratorial outcome of different age-onset systemic lupus erythematosus patients in Jiangsu, China: a multicentre retrospective study. Sci Rep 2022;12:10683. [PMID: 35739306 DOI: 10.1038/s41598-022-14840-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 16 |
Smith EMD, Egbivwie N, Jorgensen AL, Ciurtin C, Al-Abadi E, Armon K, Bailey K, Brennan M, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, Malik G, McLaren Z, Pilkington C, Ramanan AV, Rangaraj S, Ratcliffe A, Riley P, Sen E, Sridhar A, Wilkinson N, Wood F, Beresford MW, Hedrich CM. Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. Clin Immunol 2022;239:109028. [PMID: 35513304 DOI: 10.1016/j.clim.2022.109028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Al-Mayouf SM, Akbar L, Abdwani R, Ginesi G, Volpi S, Gattorno M, Bakry R, AlHashim S, Alsaleem A. Performance of the EULAR/ACR 2019 classification criteria for systemic lupus erythematous in monogenic lupus. Clin Rheumatol 2022. [PMID: 35590114 DOI: 10.1007/s10067-022-06209-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Scheffler Mendoza SC, Rivas-larrauri FE, Rodríguez-lozano AL. Updates on Childhood-Onset Systemic Lupus Erythematosus. Common Pediatric Diseases: an Updated Review 2022. [DOI: 10.2174/9789815039658122010014] [Reference Citation Analysis]
|
| 19 |
Kifer N, Sestan M, Frkovic M, Kifer D, Kozmar A, Padjen I, Potocki K, Anic B, Batinic D, Malcic I, Jelusic M. 2019 ACR/EULAR classification criteria and therapy in predicting organ damage accrual in patients with childhood-onset systemic lupus erythematosus: A retrospective study over the last 29 years. Lupus 2022;:9612033221094707. [PMID: 35410557 DOI: 10.1177/09612033221094707] [Reference Citation Analysis]
|
| 20 |
Kisaoglu H, Baba O, Kalyoncu M. Hematologic manifestations of juvenile systemic lupus erythematosus: An emphasis on anemia. Lupus. [DOI: 10.1177/09612033221093508] [Reference Citation Analysis]
|
| 21 |
Beaulieu Q, Zhang D, Melki I, Baudouin V, Goldwirst L, Woillard JB, Jacqz-Aigrain E. Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus. Eur J Clin Pharmacol 2022. [PMID: 35294622 DOI: 10.1007/s00228-022-03295-1] [Reference Citation Analysis]
|
| 22 |
Lerkvaleekul B, Apiwattanakul N, Tangnararatchakit K, Jirapattananon N, Srisala S, Vilaiyuk S. Associations of lymphocyte subpopulations with clinical phenotypes and long-term outcomes in juvenile-onset systemic lupus erythematosus. PLoS One 2022;17:e0263536. [PMID: 35130317 DOI: 10.1371/journal.pone.0263536] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 23 |
Gallagher KL, Patel P, Beresford MW, Smith EMD. What Have We Learnt About the Treatment of Juvenile-Onset Systemic Lupus Erythematous Since Development of the SHARE Recommendations 2012? Front Pediatr 2022;10:884634. [PMID: 35498799 DOI: 10.3389/fped.2022.884634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Minden K, Wagner N, Zepp F. Impfungen in der pädiatrischen Rheumatologie. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_33] [Reference Citation Analysis]
|
| 25 |
Wagner N, Haffner D, Tenbrock K, Dannecker G. Systemischer Lupus erythematodes bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_38] [Reference Citation Analysis]
|
| 26 |
Vollbach K, Schuetz C, Hedrich CM, Speth F, Mönkemöller K, Brunner J, Neudorf U, Rietschel C, Hospach A, Kallinich T, Hinze C, Wagner N, Tönshoff B, Weber LT, Latta K, Thumfart J, Bald M, Wiemann D, Zappel H, Tenbrock K, Haffner D. Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria. Front Pediatr 2022;10:851998. [PMID: 35529329 DOI: 10.3389/fped.2022.851998] [Reference Citation Analysis]
|
| 27 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2022. [DOI: 10.1007/978-3-662-60410-6_39] [Reference Citation Analysis]
|
| 28 |
John RM, Kenney-riley K. Care of the Child with a Possible Rheumatological Disorder. Pediatric Diagnostic Labs for Primary Care: An Evidence-based Approach 2022. [DOI: 10.1007/978-3-030-90642-9_12] [Reference Citation Analysis]
|
| 29 |
Bakutenko IY, Haurylchyk ID, Nikitchenko NV, Sechko EV, Kozyro IA, Tchitchko AM, Batyan GM, Sukalo AV, Ryabokon NI. Neutrophil cytosolic factor 2 (NCF2) gene polymorphism is associated with juvenile-onset systemic lupus erythematosus, but probably not with other autoimmune rheumatic diseases in children. Mol Genet Genomic Med 2021;:e1859. [PMID: 34971477 DOI: 10.1002/mgg3.1859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 30 |
Eissa E, Morcos B, Dorgham D, Kholoussi N. Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients. Arch Rheumatol 2022;37:417-23. [PMID: 36589613 DOI: 10.46497/ArchRheumatol.2022.9217] [Reference Citation Analysis]
|
| 31 |
Alexander T, Hedrich CM. Systemic lupus erythematosus - Are children miniature adults? Clin Immunol 2021;234:108907. [PMID: 34890808 DOI: 10.1016/j.clim.2021.108907] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 32 |
Figueiredo-braga M, Silva B, Ganhão S, Aguiar F, Cornaby C, Brito I, Poole BD. Kidney Function, Age, and Education as Contributors to Depression and Anxiety in Juvenile Systemic Lupus Erythematosus. EJIHPE 2021;11:1503-15. [DOI: 10.3390/ejihpe11040107] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 33 |
Cody EM, Brunner HI. Biomarkers in Childhood-Onset Systemic Lupus Erythematosus. Rheum Dis Clin North Am 2022;48:271-85. [PMID: 34798952 DOI: 10.1016/j.rdc.2021.09.003] [Reference Citation Analysis]
|
| 34 |
Alexander T, Hedrich CM. [Systemic lupus erythematosus-are children small adults?]. Z Rheumatol 2021. [PMID: 34748078 DOI: 10.1007/s00393-021-01116-x] [Reference Citation Analysis]
|
| 35 |
Ozturk K, Caglayan S, Tanatar A, Baglan E, Yener Otar G, Kavrul Kayaalp G, Karadag SG, Demir F, Sonmez HE, Ozdel S, Cakan M, Aktay Ayaz N, Sozeri B; PeRA-Research Group. Low disease activity state in juvenile-onset systemic lupus erythematosus. Lupus 2021;30:2144-50. [PMID: 34723709 DOI: 10.1177/09612033211054399] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 36 |
Eesa NN, Abdel Nabi H, Owaidy RE, Khalifa I, Radwan AR, NourEl-Din AM, Amer MA, ElShereef RR, Hassan E, Ismail F, El-Gazzar II, Khalil NM, Moshrif AH, Abualfadl E, Tharwat S, Fathi HM, Abd Elazeem MI, El-Shebini E, Samy N, Noshy N, El-Bahnasawy AS, Abdalla AM, Abousehly OS, Mohamed EF, Nasef SI, Elsaman AM, ElKhalifa M, Salem MN, Abaza NM, Fathy HM, Abdel Salam N, El-Saadany HM, El-Najjar AR, El-Hammady DH, Hammam N, Mohammed RH, Gheita TA; Egyptian College of Rheumatology (ECR) SLE Study Group. Systemic lupus erythematosus children in Egypt: Homeland spectrum amid the global situation. Lupus 2021;30:2135-43. [PMID: 34528835 DOI: 10.1177/09612033211043010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 37 |
Giani T, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Pregnolato F, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Cimaz R, Beresford MW, Hedrich CM; UK JSLE Cohort Study. Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. Lupus 2021;30:1955-65. [PMID: 34601989 DOI: 10.1177/09612033211045050] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 38 |
Sete MRC, Carlos JC, Mello-Neto JM, Lira-Junior R, Brito F, Bostrom EA, Sztajnbok FR, Figueredo CM. Impact of chronic gingivitis management on the cytokine and anti-PPAD expressions in juvenile systemic lupus erythematosus: A six-month follow-up. J Periodontal Res 2021;56:1132-40. [PMID: 34510434 DOI: 10.1111/jre.12924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 39 |
Kishi T, Sakai R, Tani Y, Nagata S, Katsumata Y, Miyamae T, Harigai M. Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18. Mod Rheumatol 2021:roab038. [PMID: 34908147 DOI: 10.1093/mr/roab038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 40 |
Greenan-Barrett J, Doolan G, Shah D, Virdee S, Robinson GA, Choida V, Gak N, de Gruijter N, Rosser E, Al-Obaidi M, Leandro M, Zandi MS, Pepper RJ, Salama A, Jury EC, Ciurtin C. Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus. Int J Mol Sci 2021;22:7619. [PMID: 34299237 DOI: 10.3390/ijms22147619] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 41 |
Carlsson E, Midgley A, Perkins S, Caamano-Gutierrez E, Gritzfeld JF, Beresford MW, Hedrich CM. Serum protein signatures differentiate paediatric autoimmune/inflammatory disorders. Clin Immunol 2021;229:108790. [PMID: 34197952 DOI: 10.1016/j.clim.2021.108790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 42 |
Drohan A, Snyder A, Plante J, Karlin S, Wine Lee L, Cotton CH. Neonatal lupus erythematosus presenting as orolabial ulcerations: Two cases and a review of the literature. Pediatr Dermatol 2021;38:643-6. [PMID: 33675085 DOI: 10.1111/pde.14555] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 43 |
Charras A, Smith E, Hedrich CM. Systemic Lupus Erythematosus in Children and Young People. Curr Rheumatol Rep 2021;23:20. [PMID: 33569643 DOI: 10.1007/s11926-021-00985-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 44 |
Levinsky Y, Broide M, Kagan S, Goldberg O, Scheuerman O, Tal R, Tirosh I, Butbul Y, Furst DE, Harel L, Amarilyo G. Performance of 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in a paediatric population—a multicentre study. Rheumatology 2021. [DOI: 10.1093/rheumatology/keab140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 45 |
Massias JS, Smith EM, Al-Abadi E, Armon K, Bailey K, Ciurtin C, Davidson J, Gardner-Medwin J, Haslam K, Hawley DP, Leahy A, Leone V, McErlane F, Mewar D, Modgil G, Moots R, Pilkington C, Ramanan AV, Rangaraj S, Riley P, Sridhar A, Wilkinson N, Beresford MW, Hedrich CM. Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. Lupus 2021;30:597-607. [PMID: 33413005 DOI: 10.1177/0961203320984251] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 46 |
Baglan E, Ozdel S, Uysal Yazıcı M, Azapağası E, Çelik H, Yüksel D, Uçan B, Karakaya D, Bulbul M. A novel therapeutic approach using the Zipper method to treat chorea in a pediatric-onset systemic lupus erythematosus patient. Lupus 2021;30:502-9. [PMID: 33413004 DOI: 10.1177/0961203320984013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 47 |
Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus. Paediatr Drugs 2021;23:331-47. [PMID: 34244988 DOI: 10.1007/s40272-021-00457-z] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 48 |
Hedrich CM, Kallinich T. Antiphospholipid-Syndrom bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_39-1] [Reference Citation Analysis]
|
| 49 |
Wagner N, Haffner D, Tenbrock K, Dannecker G. Systemischer Lupus erythematodes bei Kindern und Jugendlichen. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_38-1] [Reference Citation Analysis]
|
| 50 |
Minden K, Wagner N, Zepp F. Impfungen in der pädiatrischen Rheumatologie. Pädiatrische Rheumatologie 2021. [DOI: 10.1007/978-3-662-60411-3_33-1] [Reference Citation Analysis]
|
| 51 |
McCann LJ, Hedrich CM. Is it time to re-think juvenile-onset Rheumatic and Musculoskeletal Diseases? - First steps towards individualised treatments to meet agreed targets. Clin Immunol 2021;223:108647. [PMID: 33310069 DOI: 10.1016/j.clim.2020.108647] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 52 |
Yan HB, Li YM. Atrial thrombus as a complication of SLE and APS in an 8-year-old child. Pediatr Rheumatol Online J 2020;18:90. [PMID: 33203428 DOI: 10.1186/s12969-020-00484-z] [Reference Citation Analysis]
|
| 53 |
Janthongsri T, Wisuthsarewong W, Nitiyarom R. Photoprotective habits in children with systemic lupus erythematosus. Lupus 2020;29:964-9. [PMID: 32517570 DOI: 10.1177/0961203320930098] [Reference Citation Analysis]
|
